Skip to main content
Log in

Hepatic apoptosis can modulate liver fibrosis through TIMP1 pathway

  • Original Paper
  • Published:
Apoptosis Aims and scope Submit manuscript

Abstract

Apoptotic injury participates in hepatic fibrosis, but the molecular mechanisms are not well understood. The present study aimed to investigate the role of inducible TIMP1 in the pathogenesis of hepatic apoptosis-fibrosis. Apoptosis was induced with GCDC, LPS, and alcohol in precision-cut liver slices or bile duct ligation (BDL) in rats, as reflected by caspase-3 activity, TUNEL assay, and apoptosis-related gene profiles. The hepatic fibrosis was detected with Picrosirius staining, hydroxyproline determination, and expression profiling of fibrosis-related genes. Levels of TIMP1 were upregulated by the hepatic apoptosis, but downregulated by caspase inhibitor. The inducible TIMP1 was apoptosis-dependent. Once TIMP1 was inhibited with treatment of TIMP1-siRNA, the fibrotic response was reduced as demonstrated by hydroxyproline assay. In addition, the expression of fibrosis-related genes aSMA, CTGF, and TGFb2r were down-regulated subsequent to the treatment of TIMP1-siRNA. TIMP1 could mediate the expression of fibrosis-related genes. TIMP1 was transcriptionally regulated by nuclear factor c-Jun as demonstrated by EMSA and ChIP assay. The treatment of c-Jun siRNA could significantly decrease the expression of TIMP1 induced by alcohol, GCDC, or LPS treatment. Hepatic apoptosis induces the expression of TIMP1. Inducible TIMP1 can modulate the expression of fibrosis-related genes in liver. TIMP1 pathway is a potential target for therapeutic intervention of fibrotic liver diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Abbreviations

PCLS:

Precision-cut liver slices

TIMP1:

Tissue inhibitor of metalloproteinase-1

GCDC:

Glycochenodeoxycholate

LPS:

Lipopolysaccharide

EtOH:

Alcohol

BDL:

Bile duct ligation

TUNEL:

Terminal deoxynucleotidyl transferase dUTP nick end labeling

EMSA:

Electrophoretic mobility shift assay

ChIP assay:

Chromatin immunoprecipitation assay

References

  1. Malhi H, Guicciardi ME, Gores GJ (2010) Hepatocyte death: a clear and present danger. Physiol Rev 90(3):1165–1194

    Article  PubMed  CAS  Google Scholar 

  2. Wang K, Brems JJ, Gamelli RL, Ding J (2005) Reversibility of caspase activation and its role during glycochenodeoxycholate-induced hepatocyte apoptosis. J Biol Chem 280(25):23490–23495

    Article  PubMed  CAS  Google Scholar 

  3. Chandler JM, Cohen GM, MacFarlane M (1998) Different subcellular distribution of caspase-3 and caspase-7 following Fas-induced apoptosis in mouse liver. J Biol Chem 273:10815–10818

    Article  PubMed  CAS  Google Scholar 

  4. Leist M, Jaattela M (2001) Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2(8):589–598

    Article  PubMed  CAS  Google Scholar 

  5. Simbulan-Rosenthal CM, Rosenthal DS, Iyer S, Boulares AH, Smulson ME (1998) Transient poly(ADP-ribosyl)ation of nuclear proteins and role of poly(ADP-ribose) polymerase in the early stages of apoptosis. J Biol Chem 273(22):13703–13712

    Article  PubMed  CAS  Google Scholar 

  6. Khokha R, Waterhouse P (1994) The role of tissue inhibitor of metalloproteinase-1 in specific aspects of cancer progression and reproduction. J Neurooncol 18(2):123–127

    Article  PubMed  CAS  Google Scholar 

  7. McIntush EW, Smith MF (1998) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in ovarian function. Rev Reprod 3(1):23–30

    Article  PubMed  CAS  Google Scholar 

  8. Sluijter JP, de Kleijn DP, Pasterkamp G (2006) Vascular remodeling and protease inhibition—bench to bedside. Cardiovasc Res 69(3):595–603

    Article  PubMed  CAS  Google Scholar 

  9. Brew K, Dinakarpandian D, Nagase H (2000) Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477(1–2):267–283

    Article  PubMed  CAS  Google Scholar 

  10. Hornebeck W (2003) Down-regulation of tissue inhibitor of matrix metalloprotease-1 (TIMP-1) in aged human skin contributes to matrix degradation and impaired cell growth and survival. Pathol Biol (Paris) 51(10):569–573

    Article  CAS  Google Scholar 

  11. Soini Y, Satta J, Määttä M, Autio-Harmainen H (2001) Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart. J Pathol 194(2):225–231

    Article  PubMed  CAS  Google Scholar 

  12. Gardner J, Ghorpade A (2003) Tissue inhibitor of metalloproteinase (TIMP)-1: the TIMPed balance of matrix metalloproteinases in the central nervous system. J Neurosci Res 74(6):801–806

    Article  PubMed  CAS  Google Scholar 

  13. Offenberg H, Brünner N, Mansilla F, Orntoft Torben F, Birkenkamp-Demtroder K (2008) TIMP-1 expression in human colorectal cancer is associated with TGF-B1, LOXL2, INHBA1, TNF-AIP6 and TIMP-2 transcript profiles. Mol Oncol 2(3):233–240

    Article  PubMed  Google Scholar 

  14. Lai R, Rassidakis GZ, Medeiros LJ, Ramdas L, Goy AH, Cutler C, Fujio Y, Kunisada K, Amin HM, Gilles F (2004) Signal transducer and activator of transcription-3 activation contributes to high tissue inhibitor of metalloproteinase-1 expression in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Am J Pathol 164(6):2251–2258

    Article  PubMed  CAS  Google Scholar 

  15. Bramhall SR, Stamp GW, Dunn J, Lemoine NR, Neoptolemos JP (1996) Expression of collagenase (MMP2), stromelysin (MMP3) and tissue inhibitor of the metalloproteinases (TIMP1) in pancreatic and ampullary disease. Br J Cancer 73(8):972–978

    Article  PubMed  CAS  Google Scholar 

  16. Fong KM, Kida Y, Zimmerman PV, Smith PJ (1996) TIMP1 and adverse prognosis in non-small cell lung cancer. Clin Cancer Res 2(8):1369–1372

    PubMed  CAS  Google Scholar 

  17. Simi L, Andreani M, Davini F, Janni A, Pazzagli M, Serio M, Orlando C (2004) Simultaneous measurement of MMP9 and TIMP1 mRNA in human non small cell lung cancers by multiplex real time RT-PCR. Lung Cancer 45(2):171–179

    Article  PubMed  Google Scholar 

  18. Ricca TI, Liang G, Suenaga AP, Han SW, Jones PA, Jasiulionis MG (2009) Tissue inhibitor of metalloproteinase 1 expression associated with gene demethylation confers anoikis resistance in early phases of melanocyte malignant transformation. Transl Oncol 2(4):329–340

    PubMed  Google Scholar 

  19. Iredale J (2008) Defining therapeutic targets for liver fibrosis: exploiting the biology of inflammation and repair. Pharmacol Res 58(2):129–136

    Article  PubMed  CAS  Google Scholar 

  20. Yoshiji H, Kuriyama S, Miyamoto Y, Thorgeirsson UP, Gomez DE, Kawata M, Yoshii J, Ikenaka Y, Noguchi R, Tsujinoue H, Nakatani T, Thorgeirsson SS, Fukui H (2000) Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model. Hepatology 32(6):1248–1254

    Article  PubMed  CAS  Google Scholar 

  21. Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, Hovell C, Arthur MJ (1998) Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 102(3):538–549

    Article  PubMed  CAS  Google Scholar 

  22. Leroy V, Monier F, Bottari S, Trocme C, Sturm N, Hilleret MN, Morel F, Zarski JP (2004) Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid. Am J Gastroenterol 99(2):271–279

    Article  PubMed  CAS  Google Scholar 

  23. Guicciardi ME, Gores GJ (2010) Apoptosis as a mechanism for liver disease progression. Semin Liver Dis 30(4):402–410

    Article  PubMed  CAS  Google Scholar 

  24. Torok NJ (2007) Apoptotic cell death takes its toll. Hepatology 46(5):1323–1325

    Article  PubMed  CAS  Google Scholar 

  25. Witek RP, Stone WC, Karaca FG, Syn WK, Pereira TA, Agboola KM, Omenetti A, Jung Y, Teaberry V, Choi SS, Guy CD, Pollard J, Charlton P, Diehl AM (2009) Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis. Hepatology 50(5):1421–1430

    Article  PubMed  CAS  Google Scholar 

  26. Olinga P, Merema M, Hof IH, de Jong KP, Slooff MJ, Meijer DK, Groothuis GM (1998) Effect of human liver source on the functionality of isolated hepatocytes and liver slices. Drug Metab Dispos 26:5–11

    PubMed  CAS  Google Scholar 

  27. Clouzeau-Girard H, Guyot C, Combe C, Moronvalle-Halley V, Housset C, Lamireau T, Rosenbaum J, Desmoulière A (2006) Effects of bile acids on biliary epithelial cell proliferation and portal fibroblast activation using rat liver slices. Lab Invest 86(3):275–285

    Article  PubMed  CAS  Google Scholar 

  28. Elferink MG, Olinga P, Draaisma AL, Merema MT, Faber KN, Slooff MJ, Meijer DK, Groothuis GM (2004) LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. Am J Physiol Gastrointest Liver Physiol 287(5):1008–1016

    Article  Google Scholar 

  29. Sawyer JS, Daller JA, Brendel K, Yohem K, Putnam CW (1994) The hepatotoxicities of endotoxin and ethanol comparisons in vitro using the precision-cut rat liver slice model. Life Sci 55(18):1407–1417

    Article  PubMed  CAS  Google Scholar 

  30. Wang K, Brems JJ, Gamelli RL, Holterman AX (2010) Survivin signaling is regulated through nuclear factor-kappa B pathway during glycochenodeoxycholate-induced hepatocyte apoptosis. Biochim Biophys Acta 1803(12):1368–1375

    Article  PubMed  CAS  Google Scholar 

  31. Nieto N (2006) Oxidative-stress and IL-6 mediate the fibrogenic effects of [corrected] Kupffer cells on stellate cells. Hepatology 44(6):1487–1501

    Article  PubMed  CAS  Google Scholar 

  32. Arias M, Sauer-Lehnen S, Treptau J, Janoschek N, Theuerkauf I, Buettner R, Gressner AM, Weiskirchen R (2003) Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats. BMC Gastroenterol 3:29

    Article  PubMed  Google Scholar 

  33. Li G, Xie Q, Shi Y, Li D, Zhang M, Jiang S, Zhou H, Lu H, Jin Y (2006) Inhibition of connective tissue growth factor by siRNA prevents liver fibrosis in rats. J Gene Med 8(7):889–900

    Article  PubMed  CAS  Google Scholar 

  34. Vanhulle VP, Neyrinck AM, Pycke JM, Horsmans Y, Delzenne NM (2006) Role of apoptotic signaling pathway in metabolic disturbances occurring in liver tissue after cryopreservation: study on rat precision-cut liver slices. Life Sci 78(14):1570–1577

    Article  PubMed  CAS  Google Scholar 

  35. Bahr MJ, Vincent KJ, Arthur MJ, Fowler AV, Smart DE, Wright MC, Clark IM, Benyon RC, Iredale JP, Mann DA (1999) Control of the tissue inhibitor of metalloproteinases-1 promoter in culture-activated rat hepatic stellate cells: regulation by activator protein-1 DNA binding proteins. Hepatology 29(3):839–848

    Article  PubMed  CAS  Google Scholar 

  36. Stepniak E, Ricci R, Eferl R, Sumara G, Sumara I, Rath M, Hui L, Wagner EF (2006) c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38MAPK activity. Genes Dev 20:2306–2314

    Article  PubMed  CAS  Google Scholar 

  37. Nieto N, Rojkind M (2007) Repeated whiskey binges promote liver injury in rats fed a cholinedeficient diet. J Hepatol 46(2):330–339

    Article  PubMed  CAS  Google Scholar 

  38. Gieseler RK, Marquitan G, Schlattjan M, Sowa JP, Bechmann LP, Timm J, Roggendorf M, Gerken G, Friedman SL, Canbay A (2011) Hepatocyte apoptotic bodies encasing nonstructural HCV proteins amplify hepatic stellate cell activation: implications for chronic hepatitis C. J Viral Hepat 18(11):760–767

    Article  PubMed  CAS  Google Scholar 

  39. Vorotnikova E, Tries M, Braunhut S (2004) Retinoids and TIMP1 prevent radiation-induced apoptosis of capillary endothelial cells. Radiat Res 161(2):174–184

    Article  PubMed  CAS  Google Scholar 

  40. Li GY, Fridman R, Kim HRC (1999) Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells. Cancer Res 59:6267–6275

    PubMed  CAS  Google Scholar 

  41. Swiderski RE, Dencoff JE, Floerchinger CS, Shapiro SD, Hunninghake GW (1998) Differential expression of extracellular matrix remodeling genes in a murine model of bleomycin-induced pulmonary fibrosis. Am J Pathol 152(3):821–828

    PubMed  CAS  Google Scholar 

  42. Venugopal SK, Jiang J, Kim TH, Li Y, Wang SS, Torok NJ, Wu J, Zern MA (2010) Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation. Am J Physiol Gastrointest Liver Physiol 298(1):101–106

    Article  Google Scholar 

  43. Fowell AJ, Collins JE, Duncombe DR, Pickering JA, Rosenberg WM, Benyon RC (2011) Silencing tissue inhibitors of metalloproteinases (TIMPs) with short interfering RNA reveals a role for TIMP-1 in hepatic stellate cell proliferation. Biochem Biophys Res Commun 407(2):277–282

    Article  PubMed  CAS  Google Scholar 

  44. Nie QH, Zhang YF, Xie YM, Luo XD, Shao B, Li J, Zhou YX (2006) Correlation between TIMP-1 expression and liver fibrosis in two rat liver fibrosis models. World J Gastroenterol 12(19):3044–3049

    PubMed  CAS  Google Scholar 

  45. Wang H, Lafdil F, Wang L, Yin S, Feng D, Gao B (2011) Tissue inhibitor of metalloproteinase 1 (TIMP-1) deficiency exacerbates carbon tetrachloride-induced liver injury and fibrosis in mice: involvement of hepatocyte STAT3 in TIMP-1 production. Cell Biosci 1(1):14

    Article  PubMed  CAS  Google Scholar 

  46. Schrum LW, Black D, Iimuro Y, Rippe RA, Brenner DA, Behrns KE (2000) c-Jun does not mediate hepatocyte apoptosis following NFkappaB inhibition and partial hepatectomy. J Surg Res 88(2):142–149

    Article  PubMed  CAS  Google Scholar 

  47. Behrens A, Sibilia M, David JP, Möhle-Steinlein U, Tronche F, Schütz G, Wagner EF (2002) Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-jun in the liver. EMBO J 21(7):1782–1790

    Article  PubMed  CAS  Google Scholar 

  48. Eferl R, Ricci R, Kenner L, Zenz R, David JP, Rath M, Wagner EF (2003) Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53. Cell 112(2):181–192

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kewei Wang.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 616 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, K., Lin, B., Brems, J.J. et al. Hepatic apoptosis can modulate liver fibrosis through TIMP1 pathway. Apoptosis 18, 566–577 (2013). https://doi.org/10.1007/s10495-013-0827-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10495-013-0827-5

Keywords

Navigation